Recombinant Human LIGHT Protein (Active)
- Premium Bioactive
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human LIGHT Protein (Active) is a Human Fragment protein, in the 74 to 240 aa range, expressed in HEK 293 cells, <0.005 EU/µg endotoxin level, suitable for SDS-PAGE, Mass Spec, Biological Activity, HPLC, FuncS.
View Alternative Names
CD258, HVEML, LIGHT, UNQ391/PRO726, TNFSF14, Tumor necrosis factor ligand superfamily member 14, Herpes virus entry mediator ligand, HVEM-L, Herpesvirus entry mediator ligand
- Mass Spec
Lab
Mass Spectrometry - Recombinant Human LIGHT Protein (Active) (AB283905)
Mass determination by ESI-TOF. Predicted MW is 18266.7 (+/- 10 Da by ESI-TOF). Observed MW is 18268.40 Da.
- Biochemical assay
Supplier Data
Biochemical assay - Recombinant Human LIGHT Protein (Active) (AB283905)
Fully biologically active determined by the dose dependent proliferation of HUVEC. ED50<= 0.83 ng/ml, corresponding to a specific activity of 1.2x106 units/mg.
Cell based assay testing is performed on the first lot of the protein only and is provided as a reference for protein activity; subsequent lots of protein must pass all biophysical quality control parameters that meet the same parameters as the first lot : Lot GR3432040-1.
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant Human LIGHT Protein (Active) (AB283905)
SDS-PAGE analysis of ab283905.
- HPLC
Supplier Data
HPLC - Recombinant Human LIGHT Protein (Active) (AB283905)
HPLC analysis of ab 283905.
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
LIGHT plays a role in regulating immune responses and inflammation. It is part of a complex formed when it binds to its receptors influencing the proliferation and survival of immune cells such as T cells. LIGHT's interaction with HVEM can modulate T cell signaling cytokine production and dendritic cell maturation. It contributes to the organization of secondary lymphoid organs impacting immune surveillance and homeostasis. The presence of "APC LIGHT" indicates its involvement in antigen-presenting cell activities essential for adaptive immunity.
Pathways
LIGHT operates within the TNF receptor superfamily signaling pathway. This pathway involves other TNF members like TNF-α and lymphotoxin alfa which can also interact with LTβR. Another relevant pathway is the NF-kB signaling cascade which LIGHT activation can trigger. This cascade regulates gene expression related to immune response and cell survival. In connection to these pathways LIGHT's interaction with proteins like HVEM and LTβR helps maintain immune system balance.
Specifications
Form
Lyophilized
Additional notes
SDS PAGE>=95% Purity
General info
Function
Cytokine that binds to TNFRSF3/LTBR. Binding to the decoy receptor TNFRSF6B modulates its effects. Acts as a ligand for TNFRSF14/HVEM (PubMed : 10754304, PubMed : 9462508). Upon binding to TNFRSF14/HVEM, delivers costimulatory signals to T cells, leading to T cell proliferation and IFNG production (PubMed : 10754304).
Sequence similarities
Belongs to the tumor necrosis factor family.
Post-translational modifications
N-glycosylated.. The soluble form of isoform 1 derives from the membrane form by proteolytic processing.
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com